Word

TOLERO PHARMACEUTICALS

Status

Registered

Status Code

700

Status Date

Tuesday, July 3, 2018

Serial Number

79212382

Registration Number

5505386

Registration Date

Tuesday, July 3, 2018

Mark Type

4000

Filing Date

Wednesday, March 22, 2017

Published for Opposition

Tuesday, April 17, 2018

Trademark Owner History

Sumitomo Dainippon Pharma Co., Ltd. - Original Registrant

Classifications

5 Pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the central nervous system, namely, diseases of the brain, movement, ocular motility and spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy and Parkinson's disease and central nervous systems infections; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the peripheral nervous system, namely, amyotrophic lateral sclerosis, numbness, lightheadedness, dysuria and dyshidrosis; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the urogenital system, namely, urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the cardiovascular system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the endocrine system, namely, growth and thyroid disorders; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the metabolic system, namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the renal system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the gastroenterological system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the ophthalmologic system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the dermatologic system, namely, dermatitis, eczema, psoriasis, skin pigmentation diseases and sexually transmitted diseases; pharmaceutical preparations for the prevention and treatment of hematologic and oncologic disorders and diseases; pharmaceutical preparations for the prevention and treatment of psychiatric disorders and diseases, namely, anxiety disorders, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Parkinson's disease, Alzheimer's disease, cerebral palsy, multiple sclerosis and seizures; pharmaceutical preparations for the prevention and treatment of allergic disorders and diseases and disorders and diseases of the immune system, namely, autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of connective tissue and joints, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures and cartilage injuries; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for use in chemotherapy

44 Providing medical information

"PHARMACEUTICALS"

Trademark Events

Jul 3, 2023

Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed

Oct 26, 2018

Final Decision Transaction Processed By Ib

Oct 4, 2018

Final Disposition Notice Sent To Ib

Oct 4, 2018

Final Disposition Processed

Oct 3, 2018

Final Disposition Notice Created, To Be Sent To Ib

Jul 3, 2018

Registered-Principal Register

Apr 17, 2018

Official Gazette Publication Confirmation E-Mailed

Apr 17, 2018

Published For Opposition

Apr 13, 2018

Notification Processed By Ib

Mar 28, 2018

Notification Of Possible Opposition Sent To Ib

Mar 28, 2018

Notification Of Notice Of Publication E-Mailed

Mar 28, 2018

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Mar 15, 2018

Approved For Pub - Principal Register

Mar 14, 2018

Teas/Email Correspondence Entered

Mar 13, 2018

Correspondence Received In Law Office

Mar 13, 2018

Teas Response To Office Action Received

Dec 22, 2017

Notification Of Non-Final Action E-Mailed

Dec 22, 2017

Non-Final Action E-Mailed

Dec 22, 2017

Non-Final Action Written

Dec 19, 2017

Teas/Email Correspondence Entered

Dec 19, 2017

Correspondence Received In Law Office

Dec 15, 2017

Assigned To Lie

Dec 7, 2017

Teas Response To Office Action Received

Nov 8, 2017

Attorney/Dom.Rep.Revoked And/Or Appointed

Nov 8, 2017

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Aug 12, 2017

Refusal Processed By Ib

Jul 27, 2017

Non-Final Action Mailed - Refusal Sent To Ib

Jul 27, 2017

Refusal Processed By Mpu

Jul 25, 2017

Application Filing Receipt Mailed

Jul 21, 2017

Non-Final Action (Ib Refusal) Prepared For Review

Jul 20, 2017

Non-Final Action Written

Jul 19, 2017

Assigned To Examiner

Jul 19, 2017

New Application Office Supplied Data Entered

Jul 14, 2017

Limitation From Original Application Entered

Jul 13, 2017

Sn Assigned For Sect 66a Appl From Ib